(MENAFN- Straits Research)
Point of Care Diagnostics Market Size
The global point of care diagnostics market size was valued at USD 50.17 billion in 2025 and is projected to grow from USD 53.52 billion in 2026 to USD 89.71 billion by 2034, registering a CAGR of 6.67% during the forecast period from 2026 to 2034. North America dominated the point of care diagnostics market with a market share of 42.35% in 2025.
The rising frequency of infectious illnesses and chronic ailments, such as cardiovascular diseases, cancer, diabetes, etc., along with infectious diseases like HIV/AIDS, malaria, and others, has increased the demand for point-of-care testing. Furthermore, technological advancements in the point-of-care diagnostic technique are estimated to create opportunities for global market growth.
Point of Care Diagnostics (POC Diagnostics) refers to medical testing conducted at or near the site of patient care. These diagnostic tools provide immediate results, enabling rapid decision-making and timely treatment. POC diagnostics encompass a wide range of tests, including blood glucose monitoring, pregnancy tests, infectious disease detection, and more. These tests are designed for use in various settings such as hospitals, clinics, and even at home.
Point of Care Diagnostics Market Key Takeaways
Global Market Size & Growth
2025 Market Size: USD 50.17 Billion
2026 Market Size: USD 53.52 Billion
2034 Projected Market Size: USD 89.71 Billion
Forecast Period: 2026–2034
Base Year: 2025
Market CAGR (2026–2034): 6.67%
Regional Insights
Largest Regional Market (2025): North America
North America Market Share (2025): 42.35%
Fastest-Growing Region: Asia Pacific
Asia Pacific CAGR (2026–2034): 8.96%
Segment Insights
By Product
Leading Segment: Glucose Monitoring Kits
Market Share in 2025: 26.4%
By Mode Of Prescription
Fastest-Growing Segment: OTC Based Devices
CAGR: 7.91% (2026–2034)
By End User
Leading Segment: Professional Diagnostic Centers
Market Share in 2025: 45.6%
Download a Free Sample To learn more about this report,
Point of Care Diagnostics Market Trends
Growing Adoption of Rapid Molecular and Connected Point-of-Care Testing Technologies
The point of care diagnostics market is witnessing significant growth as healthcare providers increasingly adopt rapid testing technologies that deliver actionable results closer to patients. Advances in molecular diagnostics, biosensors, microfluidics, and portable analyzers are enabling faster detection of infectious diseases, cardiovascular conditions, diabetes, and other health disorders across hospitals, clinics, pharmacies, and home-care settings. Growing demand for decentralized healthcare and faster clinical decision-making is encouraging manufacturers to develop compact, automated, and user-friendly diagnostic platforms. Integration with digital health systems and wireless connectivity is further improving result management and remote monitoring. These developments are strengthening decentralized diagnostic capabilities and contributing to overall point of care diagnostics market growth.
In March 2025, Roche received U.S. FDA 510(k) clearance for its cobas liat molecular tests for sexually transmitted infections, expanding rapid PCR-based testing capabilities at the point of care. This development strengthened decentralized molecular diagnostics and reflected positive Point of Care Diagnostics Market analysis.
Point of Care Diagnostics Market Dynamics
Market Drivers
Growing Demand for Rapid and Decentralized Diagnostic Testing
The point of care diagnostics market is witnessing strong growth as healthcare providers increasingly require rapid test results near patients to support timely clinical decisions. Point-of-care technologies are widely used for infectious disease testing, blood glucose monitoring, cardiac biomarkers, pregnancy testing, coagulation assessment, and other diagnostic applications across hospitals, clinics, pharmacies, ambulatory facilities, and home settings. Growing prevalence of chronic and infectious diseases is further increasing testing requirements. Advances in portable analyzers, biosensors, microfluidics, and molecular diagnostics are improving test accuracy and reducing turnaround times, while decentralization of healthcare is expanding diagnostic capabilities beyond conventional centralized laboratories.
In January 2025, Roche received FDA clearance for its cobas liat molecular test detecting sexually transmitted infections, expanding rapid molecular testing capabilities that can provide results in approximately 20 minutes.
Market Restraints
High Costs and Concerns Regarding Testing Accuracy and Quality Control
The point of care diagnostics market faces restraints from the costs associated with advanced analyzers, proprietary test cartridges, reagents, maintenance, and quality-control procedures. Although point-of-care testing can provide rapid results, decentralized testing environments may create variability in sample collection, device operation, calibration, and result interpretation. Tests performed by personnel with limited laboratory training can increase the risk of operational errors when appropriate procedures are not followed. Healthcare providers must therefore maintain quality assurance, staff training, documentation, and regulatory compliance across multiple testing locations. Reimbursement limitations and comparatively high per-test costs can further restrict adoption in cost-sensitive healthcare systems.
In March 2025, diagnostic manufacturers continued expanding automated quality-control and connectivity capabilities within point-of-care platforms, reflecting industry efforts to reduce operator-related variability and maintain reliable testing performance across decentralized healthcare settings.
Market Opportunities
Integration of AI, Digital Connectivity, and Multiplex Molecular Testing
The point of care diagnostics market offers significant opportunities through artificial intelligence, connected diagnostic platforms, multiplex testing, and portable molecular technologies. Advanced systems can simultaneously identify multiple pathogens or biomarkers from a single patient sample, helping clinicians make faster and more informed treatment decisions. Integration with electronic health records and cloud-based platforms can automatically transfer results while improving disease surveillance and patient monitoring. AI-based analysis can further support interpretation of complex diagnostic information and reduce manual workflows. Growing home-based healthcare and telemedicine also create opportunities for connected diagnostic devices that enable patients to perform tests remotely while sharing results with healthcare professionals.
In June 2025, bioMérieux expanded its BIOFIRE molecular diagnostic portfolio, supporting broader adoption of rapid multiplex testing for infectious diseases across decentralized and near-patient healthcare environments.
Market Challenges
Maintaining Laboratory-Level Accuracy Across Diverse Testing Environments
The point of care diagnostics market faces challenges in delivering consistent sensitivity, specificity, and reproducibility while making devices portable, fast, and easy to operate. Tests may be performed across emergency departments, physician offices, pharmacies, ambulances, remote clinics, and homes, where environmental conditions and operator experience can vary significantly. Manufacturers must ensure that devices remain reliable despite differences in sample quality, temperature, humidity, handling, and connectivity. Increasing digital integration also creates cybersecurity and patient-data protection requirements. Achieving regulatory approval for innovative technologies while demonstrating performance comparable with centralized laboratory methods can further increase development costs and commercialization timelines.
In October 2025, Abbott continued advancing connected point-of-care diagnostic platforms and rapid testing technologies, reflecting ongoing industry efforts to combine fast decentralized testing with reliable clinical performance and digital connectivity.
Point of Care Diagnostics Market Segmental Analysis
By Product
Infectious Diseases Testing Kits is Projected to Register the Fastest Growth at a CAGR of 8.34%
The infectious diseases testing kits segment is projected to register the fastest growth in the point of care diagnostics market at a CAGR of 8.34% during the forecast period, driven by increasing demand for rapid and accessible testing for infectious conditions. Point-of-care infectious disease tests enable faster identification of infections and support timely clinical decision-making without relying entirely on centralized laboratories. Growing awareness of early disease detection, increasing availability of rapid molecular and immunoassay technologies, and rising demand for decentralized diagnostic services across hospitals, clinics, pharmacies, and community healthcare settings continue to support segment growth.
Request Customization to receive a tailored report.
By Mode Of Prescription
OTC Based Devices is Projected to Register the Fastest Growth at a CAGR of 7.91%
The OTC based devices segment is projected to register the fastest growth in the point of care diagnostics market at a CAGR of 7.91% during the forecast period, supported by increasing consumer preference for convenient, accessible, and self-administered diagnostic solutions. OTC diagnostic devices allow individuals to conduct selected health tests without requiring a prescription or visiting a conventional diagnostic facility. Growing awareness of preventive healthcare, expansion of home-based testing, improvements in user-friendly diagnostic technologies, and increasing availability of testing products through retail and digital channels continue to strengthen demand for OTC based devices.
By End User
Home Care is Projected to Register the Fastest Growth at a CAGR of 8.22%
The home care segment is projected to register the fastest growth in the point of care diagnostics market at a CAGR of 8.22% during the forecast period, driven by increasing adoption of self-testing and remote health monitoring solutions. Point-of-care diagnostic devices enable patients to perform selected tests conveniently at home, reducing dependence on frequent hospital or laboratory visits. Increasing emphasis on preventive healthcare, growing adoption of digital health technologies, rising availability of easy-to-use diagnostic kits, and increasing demand for decentralized healthcare services continue to support the expansion of point-of-care diagnostics in home care settings.
Speak to an Analyst to discuss market opportunities.
Point of Care Diagnostics Market Regional Outlook
North America Point of Care Diagnostics Market Analysis
North America dominated the point of care diagnostics market with the largest 42.35% market share in 2025, representing a market value of USD 21.25 billion. The region is projected to grow at a CAGR of 6.82% during the forecast period. Its leadership is supported by advanced healthcare infrastructure, widespread adoption of rapid diagnostic technologies, strong presence of diagnostic companies, and growing demand for decentralized testing. Point of care diagnostics are increasingly used across hospitals, clinics, emergency departments, pharmacies, and home-care settings to provide faster clinical information and support timely treatment decisions. Increasing adoption of portable and connected diagnostic platforms is further improving accessibility. Continued healthcare innovation strengthens North America's position in the global point of care diagnostics market.
United States Point of Care Diagnostics Market Insights
The United States is an important contributor to the point of care diagnostics market due to its sophisticated healthcare system, extensive diagnostic laboratory ecosystem, strong medical technology industry, and widespread adoption of rapid testing solutions. Healthcare providers use point of care technologies for glucose monitoring, infectious disease testing, cardiac assessment, coagulation testing, pregnancy testing, and other clinical applications. Growing emphasis on rapid diagnosis and decentralized healthcare is encouraging adoption across hospitals, physician offices, urgent-care facilities, pharmacies, and home settings. Development of compact analyzers, connected diagnostic devices, and digital health platforms is further expanding applications. Continued investment in diagnostic innovation supports development of the country's point of care diagnostics market.
Canada Point of Care Diagnostics Market Insights
Canada contributes to the point of care diagnostics market through its established healthcare system, increasing adoption of decentralized testing, and growing emphasis on improving diagnostic accessibility across geographically dispersed communities. Portable diagnostic technologies can support healthcare delivery in hospitals, clinics, pharmacies, remote communities, and home-care environments by reducing dependence on centralized laboratories for selected tests. Increasing demand for rapid infectious disease testing, chronic disease monitoring, and emergency diagnostics is supporting adoption. Integration of connected medical devices and digital health systems is also improving the management of diagnostic information. Continued modernization of healthcare delivery and expansion of community-based services support long-term development of Canada's point of care diagnostics market.
Unlock Regional Insights to access country-level data, & regional trends.
Asia Pacific Point of Care Diagnostics Market Analysis
Asia Pacific is the fastest-growing region in the point of care diagnostics market and is expected to expand at a CAGR of 8.96% during the forecast period. The region accounted for 21.8% of the global market in 2025, representing a market value of USD 10.94 billion. Growth is supported by expanding healthcare infrastructure, large patient populations, increasing prevalence of chronic and infectious diseases, and growing demand for accessible diagnostic services. Point of care technologies provide opportunities to extend testing beyond centralized laboratories and improve diagnostic availability across urban and underserved areas. Rising healthcare expenditure and development of domestic diagnostic manufacturing capabilities are also supporting adoption. These developments support strong expansion of the point of care diagnostics market across Asia Pacific.
Japan Point of Care Diagnostics Market Insights
Japan is an important contributor to the point of care diagnostics market through its sophisticated healthcare infrastructure, advanced medical technology industry, aging population, and strong adoption of diagnostic technologies. Point of care devices are used to support rapid testing and disease monitoring across hospitals, clinics, emergency care, and home-based healthcare environments. Growing requirements for efficient chronic disease management are encouraging adoption of compact and user-friendly diagnostic systems. Japan's expertise in electronics, sensors, miniaturization, and medical devices also supports development of increasingly sophisticated testing platforms. Integration of diagnostic technologies with digital healthcare systems further improves clinical workflows. Continued medical technology innovation strengthens Japan's contribution to the Asia Pacific point of care diagnostics market.
China Point of Care Diagnostics Market Insights
China plays a significant role in the point of care diagnostics market due to its large population, expanding healthcare infrastructure, growing diagnostic industry, and increasing demand for rapid and accessible testing services. Hospitals, community health centers, clinics, and other healthcare facilities are adopting point of care technologies for infectious disease detection, glucose monitoring, cardiac testing, and other applications. Expansion of healthcare services beyond major metropolitan areas is creating opportunities for portable diagnostic platforms that can provide results without sophisticated centralized laboratory infrastructure. Domestic manufacturers are also strengthening capabilities in diagnostic devices and test kits. Continued healthcare modernization reinforces China's importance within the Asia Pacific point of care diagnostics market.
Europe Point of Care Diagnostics Market Analysis
Europe accounted for 27.15% of the global point of care diagnostics market in 2025, reaching a market value of USD 13.62 billion. The region is anticipated to grow at a CAGR of 6.54% during the forecast period. Market development is supported by established healthcare systems, growing adoption of decentralized testing, increasing chronic disease management requirements, and continued innovation in medical diagnostics. Point of care testing enables healthcare professionals to obtain rapid diagnostic information across hospitals, clinics, emergency settings, and community healthcare facilities. Development of connected analyzers and portable diagnostic platforms is further improving clinical workflow efficiency. Increasing emphasis on accessible and timely testing supports expansion of the point of care diagnostics market across Europe.
Germany Point of Care Diagnostics Market Insights
Germany is an important contributor to the point of care diagnostics market in Europe due to its advanced healthcare infrastructure, strong medical device industry, extensive diagnostic capabilities, and widespread adoption of innovative healthcare technologies. Hospitals, physician offices, emergency departments, and other healthcare facilities utilize rapid diagnostic technologies for disease detection and patient monitoring. Demand is supported by the need for timely clinical decisions and efficient management of chronic conditions. Germany's expertise in medical engineering, laboratory diagnostics, sensors, and digital healthcare technologies supports development of sophisticated point of care systems. Continued investment in healthcare technology and decentralized diagnostic capabilities strengthens Germany's position within the European point of care diagnostics market.
United Kingdom Point of Care Diagnostics Market Insights
The United Kingdom contributes to the point of care diagnostics market through its established healthcare system, strong clinical research capabilities, expanding community healthcare services, and increasing adoption of rapid testing technologies. Point of care diagnostics can help healthcare professionals obtain timely information for infectious diseases, chronic conditions, cardiovascular disorders, and other clinical requirements. Deployment across primary care and community settings can reduce dependence on centralized laboratory testing for appropriate applications. Increasing integration of digital technologies is also supporting more efficient transfer and management of diagnostic information. Continued emphasis on accessible healthcare, rapid diagnosis, and innovative testing technologies supports the United Kingdom's contribution to the European point of care diagnostics market.
Latin America Point of Care Diagnostics Market Analysis
Latin America represented 5.25% of the global point of care diagnostics market in 2025, with a market value of USD 2.63 billion. The region is expected to register a CAGR of 7.18% during the forecast period. Growth is supported by improving healthcare infrastructure, increasing demand for accessible diagnostic services, expanding chronic disease management, and greater awareness of early disease detection. Portable testing platforms are particularly valuable for extending diagnostic capabilities to community healthcare facilities and areas with limited access to centralized laboratories. Growing investment in hospitals and diagnostic services is increasing availability of rapid testing technologies. Continued healthcare modernization and adoption of decentralized testing support expansion of the point of care diagnostics market across Latin America.
Brazil Point of Care Diagnostics Market Insights
Brazil is an important contributor to the point of care diagnostics market in Latin America due to its large healthcare system, substantial patient population, expanding diagnostic infrastructure, and growing demand for rapid testing solutions. Point of care technologies are increasingly relevant for infectious disease testing, chronic disease monitoring, emergency diagnostics, and other applications requiring timely results. Portable systems can help expand testing availability across hospitals, clinics, community health centers, and geographically dispersed populations. Increasing development of digital healthcare infrastructure also creates opportunities for connected diagnostic technologies and improved data management. Continued investment in diagnostic accessibility and healthcare modernization reinforces Brazil's importance within the regional point of care diagnostics market.
Middle East and Africa Point of Care Diagnostics Market Analysis
The Middle East and Africa accounted for 3.45% of the global point of care diagnostics market in 2025, representing a market value of USD 1.73 billion. The region is projected to expand at a CAGR of 6.73% during the forecast period. Market development is supported by improving healthcare infrastructure, growing requirements for infectious disease testing, increasing chronic disease management, and expanding access to diagnostic services. Portable and rapid testing platforms can help healthcare providers extend diagnostic capabilities to locations where centralized laboratory infrastructure remains limited. Investment in hospitals and community healthcare facilities is further improving access to modern diagnostic technologies. These factors support long-term development of the point of care diagnostics market across the region.
UAE (United Arab Emirates) Point of Care Diagnostics Market Insights
The UAE contributes to the point of care diagnostics market within the Middle East and Africa through its modern healthcare infrastructure, sophisticated hospitals, expanding digital health ecosystem, and strong adoption of advanced medical technologies. Healthcare providers increasingly utilize rapid diagnostic platforms to support timely clinical decision-making across hospitals, clinics, emergency departments, and specialized care settings. Development of connected healthcare infrastructure is creating opportunities for diagnostic devices capable of integrating test results with broader patient information systems. Growing emphasis on preventive healthcare and efficient disease management further supports adoption of decentralized testing technologies. Continued investment in medical technology and healthcare digitalization strengthens the UAE's role in the regional point of care diagnostics market.
Point of Care Diagnostics Market Competitive Landscape
The point of care diagnostics market is moderately consolidated, with major companies such as Abbott Laboratories, F. Hoffmann-La Roche, Siemens Healthineers, Danaher, QuidelOrtho, Becton Dickinson (BD), bioMérieux, QIAGEN, Werfen, Nova Biomedical, and EKF Diagnostics competing through rapid testing platforms, molecular diagnostics, immunoassays, and connected diagnostic systems. Competition is increasingly driven by faster turnaround times, portable and easy-to-use devices, multiplex testing, molecular point-of-care platforms, AI-enabled connectivity, and decentralized testing across hospitals, clinics, pharmacies, and home-care settings. Established companies are also using partnerships, acquisitions, regulatory approvals, and product launches to broaden their portfolios and strengthen geographic reach.
List of Key and Emerging Players in Point of Care Diagnostics Market
Becton
Dickinson and Company
Abbott Laboratories
F Roche
Abaxis
ACON Laboratories
BioMerieux SA
Bio-Rad Laboratories Inc
HemoCue AB (Danaher Corporation)
Dexcom Inc
Medtronic Plc
Meridian Bioscience
Trinity Biotech
Nova Biomedical
OraSure Technologies
LifeScan IP Holdings LLC
Siemens Healthineers AG
Accubiotech Co Ltd
Sysmex Corporation
Dragerwerk Ag & Co
BioLytical Laboratories Inc.
Key Industry Developments
May 2025: Abbott expanded its point-of-care diagnostics portfolio by advancing rapid testing solutions and connected diagnostic platforms, supporting faster clinical decision-making in hospitals, clinics, and decentralized healthcare settings.
June 2025: Roche expanded its point-of-care diagnostics business by strengthening near-patient testing solutions, including systems designed for faster disease detection and improved healthcare workflow efficiency.
July 2025: Siemens Healthineers expanded its point-of-care testing portfolio by advancing blood gas, immunoassay, and rapid diagnostic technologies to support decentralized testing environments.
September 2025: Danaher expanded its point-of-care diagnostics capabilities through its operating companies by advancing rapid testing platforms and diagnostic workflow solutions for healthcare providers.
Report Scope
Comments
No comment